The parking lot is empty, the phone lines are disconnected and a Connecticut building-supply company is seeking payment for doors installed several months ago.But the CEO of Pristine Pharma Corp. said production at the Massena pharmaceutical plant will ramp up later this summer after a financial audit of the company is complete.New Jersey-based Pristine first announced its plans to open a production facility in Massena in November. The company's CEO, Venkat E. Kakani, originally said the plant on County Route 42 would start production with 25 employees by as early as late March and could employ 100 by the summer of 2012.Crews worked through the winter to convert the former Michele Audio building into a pharmaceutical plant that would produce liquid medicine. By early March, Pristine hired its first seven employees here — two consultants, a chemist, a mechanical engineer, an operations staffer and two packaging employees — and produced a batch of DeWitt's Worm Syrup to be shipped to Guyana, Haiti and Jamaica, Mr. Kakani said.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment